검색어: octreotide (몰타어 - 영어)

octreotide użu għal ġol-muskoli n (%)
octreotide intramuscular use n (%)

octreotide (użat biex jittratta l-kanċer).
octreotide (used to treat cancer).

octreotide (użat għall-kura tal-kanċer)
octreotide (used to treat cancer)

somatostatin analogues bħal lanreotide u octreotide (użati biex jittrattaw akromegalija).
somatostatin analogues such as lanreotide and octreotide (used to treat acromegaly).

octreotide/lanreotide jistgħu jew iżidu jew inaqqsu l-ħtieġa tal-insulina.
octreotide/lanreotide may either increase or decrease the insulin requirement.

octreotide/lanreotide jistgħu jew iżidu jew inaqqsu l-ħtieġa għall-insulina.
octreotide/lanreotide may either increase or decrease the insulin requirement.

octreotide/ lanreotide t- tnejn jistgħu jżidu jew inaqqsu l- ħtiġijiet għall -
octreotide/ lanreotide may both decrease or increase insulin requirements.

octreotide/lanreotide jistgħu jew iżidu jew inaqqsu l-ħtieġa ta’ l-insulina.
octreotide/lanreotide may either increase or decrease the insulin requirement.

octreotide/lanreotide jistghu kemm inaqqsu kif ukoll izidu l-htiega ta’ l-insulina.
octreotide/lanreotide may both decrease and increase insulin requirement.

octreotide/ lanreotide jistg u kemm inaqqsu kif ukoll i idu l - tie a ta ’ l- insulina. tm
octreotide/ lanreotide may both decrease and increase insulin requirement. lo

octreotide/ lanreotide jistgħu t- tnejn iżidu jew inaqqsu l- ħtieġa ta ’ l- insulina.
octreotide/ lanreotide may both increase and decrease insulin requirement.

analogi ta’ somatostatin (bħal octreotide, jintużaw biex jikkuraw kundizzjoni mhux komuni fejn inti tipproduċi wisq ormon ta’ tkabbir),
omatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),

id-doża inizjali kienet ta’ 40 mg għal pasireotide użu għal ġol-muskoli u ta’ 20 mg għal octreotide użu għal ġol-muskoli.
the starting dose was 40 mg for pasireotide intramuscular use and 20 mg for octreotide intramuscular use.

l-ogħla doża permessa kienet ta’ 60 mg għal pasireotide użu għal ġol-muskoli u ta’ 30 mg għal octreotide użu għal ġol-muskoli.
maximum allowed dose was 60 mg for pasireotide intramuscular use and 30 mg for octreotide intramuscular use.

il- ħtieġa tiegħek għall- insulina tista ’ tinbidel jekk inti tieħu wkoll: inibituri ta ’ monamine oxidase (maoi); beta- blokkanti; inibituri ta ’ l- enzima li tikkonverti l- anġjotensin (ace- inhibitors); acetylsalicylic acid; sterojdi anaboliċi; sulphonamides; kontraċettivi orali; tijażidi; glukokortikojdi; terapija bl- ormoni tat- tirojdi; beta- simpatomimetiċi; ormon tat- tkabbir; danazol; octreotide jew lanreotide.
your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (maoi); beta-blockers; ace-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; beta- sympathomimetics; growth hormone; danazol; octreotide or lanreotide.